Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.770
+0.070 (4.12%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $66.17 million as of April 24, 2025. Its market cap has decreased by -82.05% in one year.
Market Cap
66.17M
Enterprise Value
-136.36M
1-Year Change
-82.05%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $66.17M, a decrease of -88.25%. That is a compound annual growth rate of -83.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 66.17M | -51.02% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 734.57B |
| UnitedHealth Group | 389.05B |
| Johnson & Johnson | 378.15B |
| AbbVie | 301.01B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 225.27B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |